Breast cancer in women with down's syndrome;Les cancers mammaires des femmes trisomiques 21

Bulletin de l'Academie Nationale de Medecine

Volumn 185, Issue 7, 2001, Pages 1239-1252

  Satgé, Daniel ^a   Sasco, Annie J ^b   Pujol, Henri ^c   Rethoré, Marie Odile ^d  

^a CENTRE HOSPITALIER   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c CENTRE VAL D AURELLE   (France)

^d Ctr Med Jerome Lejeune   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL DIFFERENTIATION; CHILD; CHROMOSOME 21; DOWN SYNDROME; FEMALE; GENE DOSAGE; GENETICS; HUMAN; INCIDENCE; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; APOPTOSIS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; FEMALE; GENE DOSAGE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDIES;

EID: 0346977278     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34447-4     Document Type: Article

References (79)

1. BERNARD J., MATHÉ G., DELORME J.C., BARNOULD O. - Les leucoses du très jeune enfant. Arch. Franc. Pédiatr., 1951, 12, 470-502.
2. SCHUNK G.J., LEHMAN W.L. - Mongolism and congenital leukaemia. JAMA, 1954, 155, 250-251.
3. HOLLAND W.W., DOLL R., CARTER C.O. - The mortality from leukaemia and other cancers among patients with Down's syndrome (Mongols) and among their parents. Br. J. Cancer, 1962, 16, 177-186.
4. CARR J. - Long term outcome for people with Down's syndrome. J. Child Psychol. Psychiat., 1994, 35, 425-439.
5. SCHOLL T., STEIN Z., HANSEN H. - Leukaemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Develop. Med. Child Neurol., 1982, 24, 817-329.
6. HASLE H., CLEMMENSEN I.H., MIKKELSEN M. - Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet, 2000, 355, 165-169.
7. SATGÉ D., SASCO A.J., CARLSEN N.L.T., STILLER C.A., RUBIE H., HERO B., DE BERNARDI B., DE KRAKER J., COZE C., KOGNER P., LANGMARK F., HAKVOORT-CAMMEL F.G., BECK D., VON DER WEID N., PARKES S., HARTMANN O., LIPPENS R.J., KAMPS W.A., SOMMELET D. - A lack of neuroblastoma in Down syndrome : a study from 11 European countries. Cancer Res., 1998, 58, 448-452.
8. OLSON J.M., HAMILTON A., BRESLOW N.E. - Non-11 p. constitutional chromosome abnormalities in Wilm's tumour patients. Med. Pediatr. Oncol., 1995, 24, 305-309.
9. SATGÉ D., SOMMELET D., GENEIX A., NISHI M., MALET P., VEKEMANS M. - A tumour profile in Down syndrome. Am. J. Med. Genet., 1998, 78, 207-216.
10. Down syndrome. In Congenital Malformations Worldwide. A report from the International Clearinghouse for Birth Defects Monitoring Systems. Amsterdam : Elsevier Scientific Publications, 1991.
11. BAIRD P.A., SADOVNICK A.D. - Life tables for Down-syndrome. Hum. Genet., 1989, 82, 291-292.
12. HILL C., DOYON F., SANCHO-GARNIER H. - Sein. In Épidémiologie des cancers. Paris : Flammarion, 1997.
13. DÖRDHLMANN M., SCHRAPPE M., REITER A., ZIMMERMANN M., GRAF N., SCHOTT G., LAMPERT F., HARBOTT J.,NIEMEYER C., RITTER J., DORFFEL W., NESSLER G., KUHL J., RIEHM H. -Down's syndrome in childhood acute lymphoblastic leukaemia : clinical characteristics and treatment outcome in four consecutive BFM trials. Leukaemia, 1998, 12, 645-651.
14. CHIK K., LI C., SHING M.M., LEUNG T., YUEN P.M. - Intracranial germ cell tumours in children with and without Down syndrome. J. Pediatr. Hematol. Oncol. 1999, 21, 149-151.
15. SATGÉ D., LE TOURNEAU A., VERGER J.P., LEFORT S., GENEIX A., MALET P., DIEBOLD J., VEKEMANS M. - A case report of Down syndrome and centroblastic lymphoma. Pathol. Res. Pract., 1996, 192, 1266-1269.
16. LAPLANCHE A. - Qualité des certificats de décès en cas de décès par cancer en France. Bull. Cancer, 1998, 85, 967-969.
17. JACKSON E.W., TURNER J.H., KLAUBER M.R., NORRIS F.D. - Down's syndrome : variation of leukaemia occurrence in institutionalized populations. J. Chron. Dis., 1968, 21, 247-253.
18. BERNARDINO J., GERBAULT-SEUREAU M., SASTRE X., DUTRILLAUX B. - Unusual clonal chromosomal evolution in a breast carcinoma and its lymph node metastasis in a patient with Down syndrome. Genes Chromosomes Cancer, 1997, 19, 195-199.
19. OSTER J., MIKKELSEN M., NIELSEN A. - Mortality and life-table in Down's syndrome. Acta Pediatr. Scand., 1975, 64, 322-326.
20. PIACHAUD J., ROHDE J. - Screening for breast cancer is necessary in patients with learning disabilities. Br. Med. J., 1998, 316, 1979-1980.
21. MOUSTACCHI E. - Mécanismes moléculaires de la cancérogenèse : Le rôle des systèmes de réparation de l'ADN. Bull. Acad. Natle Méd., 1998, 182, 33-47.
22. SANFORD K.K., PARSHAD R., PRICE F.M., TARONE R.E., SCHAPIRO M.B. - X-ray-induced chromatic damage in cells from Down syndrome and Alzheimer disease in patients in relation to DNA repair and cancer proneness. Cancer Genet. Cytogenet., 1993, 70, 25-30.
23. CAMPISI J. Aging and cancer : the double edged sword of replicative senescence. J. Am. Geriatr. Soc., 1997, 45, 482-488.
24. ROTH G.M., SUN B., GREENSITE F.S., LOTT I.T., DIETRICH R.B. - Premature aging in persons with Down syndrome : MR Findings. Am. J. Neuroradiol., 1996, 17, 1283-1289.
25. MARNETT L.J. - Oxyradicals and DNA damage. Carcinogenesis, 2000, 21, 361-370.
26. JOVANOVIC S.V., CLEMENTS D., MACLEOD K. - Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Rad. Biol. Med., 1998, 25, 1044-1048.
27. VAINIO H., WILBOURN J.D., SASCO A.J., PARTENSKY C., GAUDIN N., HESELTINE E., ERAGNE I. Identification des facteurs cancérogènes pour l'homme dans les monographies du CIRC. Bull. Cancer, 1995, 82, 339-348.
28. TODARO G.J., MARTIN G.M. - Increased susceptibility of Down's syndrome fibroblasts to transformation by SV40. Proc. Soc. Exper Biol. Med., 1967, 124, 1232-1236.
29. PENN I. - Depressed immunity and the development of cancer. Cancer Detect. Prev., 1994, 18, 241-252.
30. NESPOLI L., BURGIO G.R., UGAZIO A.G., MACCARIO R. - Immunological features of Down's syndrome : a review. J. Intel. Dis. Res., 1993, 37, 543-551.
31. CHOI S.W., MASON J.B. - Folate and carcinogenesis : an integrated scheme. J. Nutr., 2000, 130, 129-132.
32. GERICKE G.S., HESSELING P.B., BRINK S., TIEDT F.C. - Leucocyte ultrastructure and folate metabolism in Down's syndrome. S. Afr. Med. J., 1977, 51, 369-374.
33. RAYMAN M.P. - The importance of selenium to human health. Lancet, 2000, 356, 233-241.
34. KADRABOVA J., MADARIC A., SUSTROVA M., GINTER E. Changed serum trace element profile in Down's syndrome. Biol. Trace Elem. Res., 1996, 54, 201-206.
35. HIGGINSON J., MUIR C.S. - Determination de l'importance des facteurs environnementaux dans le cancer humain : rôle de l'épidémiologie. Bull. Cancer, 1977, 64, 365-384.
36. HOOVER R.N. - Cancer-Nature, nurture or both. New Engl. J. Med., 2000, 343, 135-136.
37. LICHTENSTEIN P., HOLM N.V, VERKASALO P.K., ILIADOU A., KAPRIO J., KOSKENVUO M., PUKKALA E., SKYTTHE A., HEMMINKI K. Environmental and heritable factors in the causation of cancer. N. Engl. J. Med., 2000, 343, 78-85.
38. ZIEGLER R.G., HOOVER R.N., PIKE M.C., HILDESHEIM A., NOMURA A.M.Y., WEST D.W., WU-WILLIAMS A.H., KOLONEL L.N., HORN-ROSS P.L., ROSENTHAL J.F. - Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst., 1993, 85, 1819-1827.
39. SASCO A.J. - Breast. In World Cancer Report. Lyon : IARC Press (sous presse).
40. PUESCHEL M.S. - Clinical aspects of Down syndrome from infancy to adulthood. Am. J. Med. Genet., 1990, 7, 52-56.
41. LUKE A., SUTTON M., SCHOELLER D.A., ROIZEN N.J.M. - Nutrient intake and obesity in prepubescent children with Down syndrome. J. Am. Diet. Assoc., 1996, 96, 1262-1267.
42. ZHANG S., HUNTER D.J., FORMAN M.R., ROSNER B.A., SPEIZER F.E., COLDITZ G.A., MANSON J.E., HANKINSON S.E., WILLETT W.C. - Dietary carotenoids and vitamins A, C and E and risk of breast cancer. J. Natl Cancer Inst., 1999, 91, 547-556.
43. LA MANTIA I., GRILLO C., MATTINA T., ZACCONE P., XIANG M., DI MAURO M., MERONI P.L., NICOLETTI F. - Prophylaxis with the novel immunomodulator Pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome. J Chemother., 1999, 11, 126-130.
44. BOICE J.D., PRESTON D., DAVIS F.G., MONSON R.R. - Frequent chest X-rays fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Rad. Res., 1991, 125, 214-222.
45. GOLDSTEIN H. - Menarche, menstruation, sexual relations and contraception in adolescent females with Down syndrome. Eur. J. Obset. Gynecol. Reprod Biol., 1988, 27, 343-349.
46. SHEPPERDSON B. - The control of sexuality in young people with Down's syndrome. Child Care Health Dev., 1995, 21, 333-349.
47. SASCO A.J. - Epidemiology of breast cancer : an environnemental disease ? Acta Pathol. Microbiol. Immunol. Scand., soumis pour publication.
48. TRICHOPOULOS D. - Hypothesis : does breast cancer originate in utero ? Lancet. 1990, 335, 939-940.
49. POTISCHMAN N., TROISI R. - In utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control, 1999, 10, 561-573.
50. NEWBY D., AITKEN D.A., HOWATSON A.G., CONNOR J.M. - Placental synthesis of œstriol in Down's syndrome pregnancies. Placenta, 2000, 21, 263-267.
51. RUBIN S.S., RIMMER J.H., CHICOINE B., BRADDOCK D., MCGUIRE D.E. - Overweight prevalence in persons with Down syndrome. Ment. Retard., 1998, 36, 175-181.
52. DE WAARD F., BAANDERS-VAN HALEWIJN E.A. - A prospective study in general practice on breast cancer risk in postmenopausal women. Int. J. Cancer, 1974, 14, 153-160.
53. ADAMI H.O., SIGNORELLO L.B., TRICHOPOULOS D. - Towards an understanding of breast cancer etiology. Sem. Cancer Biol., 1998, 8, 255-262.
54. PETRIKOVSKI B.M., SCHNEIDER E.P., KLEIN V.R., WYSH L.J., LESSER M. Fetal breasts in normal and Down syndrome foetuses. J. Clin. Ultras., 1996, 24, 507-511.
55. SALERNO L.J., PARK J.K., GIANNINI M.J. - Reproductive capacity of the mentally retarded. J Reprod. Med., 1975, 14, 123-129.
56. SAREEN C.K., RUVALCABA R.H.A., KELLEY V.C. - Gynecomastia in the physically and mentally handicapped. Am. J Ment. Defic., 1971, 76, 153-158.
57. ARMSTRONG K., EISEN A., WEBER B. - Assessing the risk of breast cancer. New Engl. J. Med., 2000, 342, 564-571.
58. TAKANO T., TAKAKI H., KAWANO H., NONAKA K. - Early menarche in Japanese Down syndrome. J. Pediatr., 1999, 103, 854-855.
59. SCHUPF N.,ZIGMAN W., KAPELL D., LEE J.H., KLINE J., LEVIN B. - Early menopause in women with Down's syndrome. J. Intel. Disab. Res., 1997, 41, 264-267.
60. CENTO R.M., RAGUSA L., PROTO C., ALBERTI A., ROMANO C., BOEMI G., COLABUCCI F., LANZONE A. - Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. Gynecol. Endocrinol., 1996, 10, 133-137.
61. DAVIS D.L., AXELROD D., OSBORNE M., TELANG N., BRADLOW H., SITTNER E. - Avoidable causes of breasl cancer : The known, unknown and the suspected. Ann. N.Y. Acad. Sci., 1997, 833, 112-128.
62. KEY T. J. - Serum œstradiol and breast cancer risk. Endoc. Relat. Cancer, 1999, 6, 175-180.
63. KÄLLEN B. - Down's syndrome and maternal cancer. Acta Pathol. Microbiol. Immunol. Scand., 1988, 96, 168-170.
64. FEKETE G. - Occurrence of leukaemia and other malignancies in the relatives of children with Down's syndrome. In Congenital chromosome aberrations and tumour predisposition. Budapest : Akadémiai Kiado, 1990.
65. OESTERREICH S., FUQUA S.A.W. - Tumour suppressor genes in breast cancer. Endoc. Relat. Cancer. 1999, 6, 405-419.
66. SCHWENDEL A., RICHARD F., LANGRECK H., KAUFMANN O., LAGE H., WINZER K.J., PETERSEN I., DIETEL M. - Chromosome alterations in breast carcinomas : frequent involvement of DNA losses including chromosomes 4q and 21q. Br J Cancer, 1998, 78, 806-811 .
67. KERANGUEVEN F., NOGUCHI T., COULIER F., ALLIONE F., WARGNIEZ V., SIMONY-LAFONTAINE J., JACQUEMIER J., SOBOL H., EISINGER F., BIRNBAUM D. - Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 1997, 57, 5469-5474.
68. OHGAKI K., LIDA A., KASUMI F., SAKAMOTO G., AKIMOTO M., NAKAMURA Y. - Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers. Genes Chromosom. Cancer, 1998, 23, 244-247.
69. HATTORI M., FUJIYAMA A., TAYLOR T.D., WATANABE H., YADA T., PARK H.S., TOYODA A., ISHII K., TOTOKI Y., CHOI O.K., SOEDA E., OHKI M., TAKAGI T., SAKAKI Y., TAUDIEN S., BLECHSCHMIDT K., POLLEY A., MENZEL U., DELABAR J., KUMPE K., LEHMANN R., PATTERSON D., REICHWALD K., RUMP A., SCHILLHABEL M., SCHUDY A. - The DNA sequence of human chromosome 21. Nature, 2000, 405, 311-319.
70. PRITCHARD M.A., KOLA I. - The «gene dosage effect» hypothesis versus the «amplified developmental instability»hypothesis in Down syndrome. J. Neurol. Transm., 1999, suppl 57, 293-303.
71. YOSHIDA Y., MATSUDA S., IKEMATSU N., KAWAMURA-TSUZUKU J., INAZAWA J., UMEMORI H., YAMAMOTO T. ANA, a novel member of Tob /BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene, 1998, 16, 2687-2693.
72. FOOS G., GARCIA-RAMIREZ J.J., GALANG C.K., HAUSER C.A. - Elevated expression of Ets 2 or distinct portions of Ets 2 can reverse Ras-mediated cellular transformation. J. Biol. Chem., 1998, 273, 18871-18880.
73. GELMANN E.P. Oncogenes in human breast cancer. In The Breast comprehensive management of benign and malignant diseases sous la dir. de K. Bland et E. M. Copeland. New York : Saunders, 1998.
74. HORDIJK P.L., TEN KLOOSTER J.P., VAN DER KAMMEN R.A., MICHIELS F., OOMEN L.C.J.M., COLLARD J.G. - Inhibition of invasion of epithelial cells by Tiam 1-Rac signaling. Science, 1997, 278, 1464-1466.
75. SCOTTO C., DELPHIN C., DELOULME J.C., BAUDIER J. - Concerted regulation of wild-type p53 nuclear accumulation and activation by S 100 B and calcium - dependant protein Kinase C. Molec. Cell. Biol, 1999, 19, 7168-7180.
76. MOLL U.M., LA QUAGLIA M., BÉNARD J., RIOU G. - Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumours. Proc. Natl. Acad Sci. USA, 1995, 92, 4407-4411.
77. GENTILE M., JUNGESTRÖM M.B., OLSEN K.E., SÖDERKVIST P., WINGREN S. - p. 53 and survival in early onset breast cancer : analysis of gene mutations, loss of heterozygosity and protein accumulation. Europ. J. Cancer, 1999, 35, 1202-1207.
78. ICHIHARA S., KOSHIKAWA T., NAKAMURA S., YATABE Y., KATO K. - Epithelial hyperplasia of usual type expresses both S100-alpha and S100-beta in a heterogeneous pattern but ductal carcinoma in situ can express only S100-alpha in a monotonous pattern. Histopathalogy, 1997, 30, 533-541.
79. FUNAHASHI H., KOSHIKAWA T., ICHIHARA S., OHIKE E., KATOH K. - Different distributions of immunoreactive S100-alpha and S100-beta protein expression in human breast cancer. J. Surg., Oncol., 1998, 68, 25-29.